HSK39004 Dry Powder Inhaler

HSK39004 · Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HSK39004 Dry Powder Inhaler, covering 2026-02-25 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing